Bourne Lent Asset Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-415,615
| Closed | -$41.3M | – | 61 |
|
|
2019
Q3 | $41.3M | Sell |
415,615
-7,050
| -2% | -$670K | 19.79% | 1 |
|
|
2019
Q2 | $39.1M | Hold |
422,665
| – | – | 18.73% | 1 |
|
|
2019
Q1 | $39.9M | Sell |
422,665
-1,000
| -0.2% | -$87.5K | 19.76% | 1 |
|
|
2018
Q4 | $27.2M | Sell |
423,665
-4,850
| -1% | -$358K | 16.07% | 1 |
|
|
2018
Q3 | $38.3M | Sell |
428,515
-3,030
| -0.7% | -$268K | 18.28% | 1 |
|
|
2018
Q2 | $34.3M | Sell |
431,545
-8,459
| -2% | -$702K | 18.07% | 1 |
|
|
2018
Q1 | $39.3M | Sell |
440,004
-8,050
| -2% | -$773K | 21.32% | 1 |
|
|
2017
Q4 | $46.8M | Buy |
448,054
+1,280
| +0.3% | +$144K | 25.23% | 1 |
|
|
2017
Q3 | $65.1M | Sell |
446,774
-11,650
| -3% | -$1.59M | 33.45% | 1 |
|
|
2017
Q2 | $59.5M | Sell |
458,424
-11,750
| -2% | -$1.44M | 32.52% | 1 |
|
|
2017
Q1 | $58.5M | Sell |
470,174
-3,635
| -0.8% | -$435K | 31.96% | 1 |
|
|
2016
Q4 | $54.8M | Buy |
473,809
+26,540
| +6% | +$2.96M | 32.74% | 1 |
|
|
2016
Q3 | $46.8M | Sell |
447,269
-6,673
| -1% | -$722K | 34.44% | 1 |
|
|
2016
Q2 | $44.8M | Sell |
453,942
-1,205
| -0.3% | -$125K | 35.18% | 1 |
|
|
2016
Q1 | $45.6M | Buy |
455,147
+740
| +0.2% | +$76.2K | 36.43% | 1 |
|
|
2015
Q4 | $54.4M | Sell |
454,407
-3,100
| -0.7% | -$359K | 41.18% | 1 |
|
|
2015
Q3 | $49.5M | Sell |
457,507
-3,050
| -0.7% | -$378K | 40.63% | 1 |
|
|
2015
Q2 | $53.3M | Sell |
460,557
-6,992
| -1% | -$799K | 41.93% | 1 |
|
|
2015
Q1 | $53.9M | Buy |
+467,549
| New | +$55.9M | 40.81% | 1 |
|
Other funds holding CELG
Bourne Lent Asset Management's CELG Position: Q4 2019 in Review
Bourne Lent Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 415,615 shares — an estimated $41.3M sold.
Bourne Lent Asset Management first reported a position in CELG in Q1 2015 and held it in 19 quarters. The position peaked at $65.1M in Q3 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Bourne Lent Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Bourne Lent Asset Management sold 415,615 Celgene Corp shares in Q4 2019, an estimated $41.3M.
- Bourne Lent Asset Management first reported a position in Celgene Corp in Q1 2015 and held it in 19 quarters.
- Bourne Lent Asset Management's Celgene Corp position peaked at $65.1M in Q3 2017.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Bourne Lent Asset Management's 13F filing for Q4 2019, filed 24 Jan 2020.